These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2949582)

  • 1. Potential mechanisms explaining the risk of left ventricular hypertrophy.
    Frohlich ED
    Am J Cardiol; 1987 Jan; 59(2):91A-97A. PubMed ID: 2949582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension.
    Messerli FH; Schmieder R
    Drugs; 1986; 31 Suppl 4():192-201. PubMed ID: 2942387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Messerli FH; Soria F
    Am J Med; 1992 Aug; 93(2A):21S-26S. PubMed ID: 1387763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension: left ventricular hypertrophy, ventricular ectopy, and sudden death.
    Ketelhut R; Messerli FH
    Prim Care; 1991 Sep; 18(3):577-92. PubMed ID: 1835104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy as a risk factor.
    Frohlich ED
    Cardiol Clin; 1986 Feb; 4(1):137-44. PubMed ID: 2939951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy. A crucial target for antihypertensive therapy.
    Messerli FH
    Postgrad Med; 1990 Jul; 88(1):127-8, 131, 134. PubMed ID: 2142278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
    Tarazi RC; Frohlich ED
    Circulation; 1987 Jan; 75(1 Pt 2):I113-7. PubMed ID: 2947744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ventricular arrhythmia in patients with hypertension and left ventricular hypertrophy].
    Sami MH
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():59-62. PubMed ID: 2150475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heart in hypertension: a 1991 overview.
    Frohlich ED
    Hypertension; 1991 Nov; 18(5 Suppl):III62-8. PubMed ID: 1834556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy: an independent risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S59-66; discussion S66-7. PubMed ID: 1726010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of ventricular arrhythmias in cardiac hypertrophy.
    McLenachan JM; Dargie HJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S46-9. PubMed ID: 1715485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic, hemodynamic and coronary perfusion characteristics in severe left ventricular hypertrophy secondary to systemic hypertension and evidence for nonatherosclerotic myocardial ischemia.
    Houghton JL; Carr AA; Prisant LM; Rogers WB; von Dohlen TW; Flowers NC; Frank MJ
    Am J Cardiol; 1992 Jan; 69(3):219-24. PubMed ID: 1530994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular hypertrophy, arrhythmias and sudden death in systemic hypertension.
    Borhani NO
    Am J Cardiol; 1987 Dec; 60(17):13I-18I. PubMed ID: 2961245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.
    Levy D; Anderson KM; Savage DD; Balkus SA; Kannel WB; Castelli WP
    Am J Cardiol; 1987 Sep; 60(7):560-5. PubMed ID: 2957907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of hemodynamic and non-hemodynamic factors associated with left ventricular hypertrophy.
    Frohlich ED
    J Mol Cell Cardiol; 1989 Dec; 21 Suppl 5():3-10. PubMed ID: 2534139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.